PT  - JOURNAL ARTICLE
AU  - Ortiz-Brizuela, Edgar
AU  - Carabali, Mabel
AU  - Jiang, Cong
AU  - Merckx, Joanna
AU  - Talbot, Denis
AU  - Schnitzer, Mireille E.
TI  - Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals
AID  - 10.1101/2023.11.16.23298633
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2023.11.16.23298633
4099  - http://medrxiv.org/content/early/2024/07/18/2023.11.16.23298633.short
4100  - http://medrxiv.org/content/early/2024/07/18/2023.11.16.23298633.full
AB  - The test-negative design (TND) is a popular method for evaluating vaccine effectiveness (VE). A “classical” TND study includes symptomatic individuals tested for the disease targeted by the vaccine to estimate VE against symptomatic infection. However, recent applications of the TND have attempted to estimate VE against infection by including all tested individuals, regardless of their symptoms. In this article, we use directed acyclic graphs and simulations to investigate potential biases in TND studies of COVID-19 VE arising from the use of this “alternative” approach, particularly when applied during periods of widespread testing. We show that the inclusion of asymptomatic individuals can potentially lead to collider stratification bias, uncontrolled confounding by health and healthcare-seeking behaviors (HSBs), and differential outcome misclassification. While our focus is on the COVID-19 setting, the issues discussed here may also be relevant in the context of other infectious diseases. This may be particularly true in scenarios where there is either a high baseline prevalence of infection, a strong correlation between HSBs and vaccination, different testing practices for vaccinated and unvaccinated individuals, or settings where both the vaccine under study attenuates symptoms of infection and diagnostic accuracy is modified by the presence of symptoms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork supported by the Canadian Institutes of Health Research Project Grant ECP-184178 (awarded to MES, DT, JM, CJ). MES holds the Canada Research Chair in Causal Inference and Machine Learning in Health Science. MC holds a Chercheur Boursier Junior 1 Award from the Fonds de recherche du Quebec-Sante (FRQS). DT holds a Chercheur Boursier Junior 2 Award from FRQS. E-OB holds a Doctoral Training Award from FRQS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes